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Abstract
The cerebrospinal fluid (CSF) system provides nutrients to and removes waste products from the brain. Recent
findings suggest, however, that in addition, the CSF contains message molecules in the form of actively released
neuroactive substances. The concentrations of these vary between locations, suggesting they are important for the
changes in brain activity that underlie different brain states, and induce different sensory input and behavioral out-
put relationships.
The cranial CSF displays a rapid caudally-directed ventricular flow followed by a slower rostrally-directed subarach-
noid flow (mainly towards the cribriform plate and from there into the nasal lymphatics). Thus, many brain areas
are exposed to and can be influenced by substances contained in the CSF. In this review we discuss the produc-
tion and flow of the CSF, including the mechanisms involved in the regulation of its composition. In addition, the
available evidence for the release of neuropeptides and other neuroactive substances into the CSF is reviewed,
with particular attention to the selective effects of these on distant downstream receptive brain areas. As a conclu-
sion we suggest that (1) the flowing CSF is involved in more than just nutrient and waste control, but is also used
as a broadcasting system consisting of coordinated messages to a variety of nearby and distant brain areas; (2) this
special form of volume transmission underlies changes in behavioral states.
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Introduction
Behavioral observations as well as modern imaging tech-
niques show that brain activity is an input-output pro-
cess that depends on the physiological or behavioral
state of the animal or subject. A state is a well-known
concept in mathematical system theory and in computer
science. A machine, but for that matter also an organ-
ism or even a human, is at moment t1 in the same state
as at moment t2, if for all possible input, the resulting
internal and external reactions are the same. The states
will be different if there is a particular input resulting in
different reactions. Of course, the collection of all possi-
ble input (and also reactions) is huge and in a particular
scientific discipline one restricts oneself to a set of rele-
vant inputs and reactions. Many well-known examples
of states come from animal observations, and have been
described as motivational, emotional and mental states,
or simply brain states in animal and human behavioral
studies [1-5] and in a phenomenological study [6].
Changes in behavioral states, which induce adaptive
physiological mechanisms, require a complex
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brain areas. The hypothalamus, embedded in the limbic
system is strongly involved when a motivational state
changes [3-5,7,8]. Other brain areas, such as cortical
regions or spinal cord, must be involved as well, in
order to accomplish coordinated adaptations in the
neural (sensory, motor and autonomic) as well as hor-
monal systems, that underlie goal-directed behavior.
Neural networks involved in the coordination of these
changes are complex. Synaptic communication plays a
role whenever rapid changes in neural activity are neces-
sary. However, non-synaptic or paracrine communica-
tion has been proposed as a mechanism to coordinate
changes in neuronal activity in multiple brain regions,
for a prolonged period of time [5,7-11]. These mechan-
isms, synaptic and non-synaptic, may serve the same
goal, however, and are usually well coordinated, comple-
mentary and mutually supportive, as will be discussed
later. All changes induced by these mechanisms can be
viewed as basic requirements for motivational changes.
Many neuropeptidergic fiber systems descend over long
distances, are abundantly present in behavior-relevant
brain areas, contain mostly unmyelinated varicose fibers
and lack synaptic contacts [7-15]. This combination of
characteristics puts these fibers in a most favourable
position to participate in changing the weight factors in
the neural network involved in maintaining or switching
between behavioral states [4,5]. In 1985, Nieuwenhuys
[9] wrote (p 197): “I concur with the opinion of Chan-
Palay that the periventricular part of the neural extracel-
lular space presumably communicates via ependymal
elements with the ventricular system, which in its turn
may also represent an important communication chan-
nel, acting as a vehicle for widespread distribution of
neuroactive substances”. From 1986, the term volume
transmission has been used for this type of non-synaptic
communication [16-21].
Many descending fibers showing paracrine characteris-
tics are observed close to the ventricular system
[12,14,15,22], which raises the question as to how far
the cerebrospinal fluid (CSF), flowing through the ven-
tricular system and the subarachnoid space surrounding
the brain, could be involved in behavioral changes. As
early as 1910, Cushing and Goetsch [23] discussed the
CSF circulation as a possible way to send messages to
distant parts of the brain. Using CSF, obtained from
patients with a brain tumour causing obstructive
hydrops, strong physiological reactions were observed in
rabbits after CSF injections. Later on, Cushing coined
the term “third circulation” for the CSF flowing caudally
through, as well as around, the CNS. In 1932 Friedman
and Friedman investigated the effects of CSF oxytocin
on rabbit uterus contractions and noted that the con-
centrations were effective [24]. Many years later, Borison
et al. noted that “the simple concept that the subarach-
noid space constitutes a catch basin for interstitial fluid
is no longer tenable. Rather, the CSF of that space must
be considered as being in dynamic chemical communi-
cation with all parts of the central nervous system” [25].
In 1998 a special meeting was held in Los Angeles
about a possible role of CSF in spreading the messages
and Nicholson reported on signals that go with the flow
[26]. In the present review we explore the hypothesis
that neuropeptides can be released into the CSF as mes-
sages to flow with the fluid, in order to induce changes
in motivational states, by influencing appropriate recep-
tors in distant brain areas.
The reviewed data concerning the CSF flow and the
distribution of messages support earlier proposals by
Sewards and Sewards [27,28] concerning vasopressin
and corticotrophin releasingf a c t o r( C R F ) .I nar e c e n t
paper, the presence of neuroendocrine signalling mole-
cules in the CSF, led to the conclusion that they play an
active role in the function of the nervous system [29], in
full agreement with our proposal.
Production and circulation of CSF
Anatomically, the ventricular system of the vertebrate
brain develops from a simple elongated cavity inside the
neural tube, into a highly complex structure, filled with
CSF (Fig 1) [10,30]. Vigh and others have extensively
studied the specialisations and CSF-contacting neurons
composing and surrounding the ventricular walls
[31-35].
The CSF has an essentially unidirectional flow [36];
caudal through the ventricular system and in different
directions through the cisternal subarachnoid spaces
surrounding the brain, providing the brain with a pro-
tective environment. The CSF can be characterized by
its open communication with the extracellular fluid
(ECF) of the neuropil, to such an extent that CSF has
been described as a reservoir of cerebral ECF [37]. The
intercellular junctions between the ependymal cells
determine the extent of this communication, and there
are many regional differences [32]. In addition, recent
investigations suggest that this open communication is
biased in the sense that CSF has rapid and widespread
access to the ECF, causing local interstitial oedema
when CSF-pressure is rising, like after acute hydroce-
phalus [38,39]. In the opposite direction, however, only
about 10 to 15% of the ECF drains into the CSF [40,41].
The intercellular junctions in the superficial and perivas-
cular glial limiting membranes may play a role here by
providing a separation between subarachnoid and peri-
vascular CSF space and brain ECF.
Therefore, CSF-ECF exchange of neuroactive sub-
stances is a variable and complicated process. Concen-
trations vary over time and in addition there may be
large regional concentration differences of substances.
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substances in the brain, but exist in the CSF as well,
where concentrations can vary by a factor of 10 in dif-
ferent regions of the ventricular system [36,42].
CSF has a high salt concentration (>150 mmol/l) and
low protein concentration (ca. 200-700 μg protein/ml).
It serves as a transport medium, carrying nutrients for
cells and removing products of their metabolism. How-
ever, CSF not only contains polypeptides which pass
through the blood-brain barrier but also harbours pep-
tides and proteins manufactured locally. The CSF pro-
tein population differs in composition from that of
plasma due to inherent CSF functions, such as ongoing
proteolytic processes involved in cell surface remodeling,
protein shedding, and synthesis of regulatory peptides
[36,43,44]. Blood-derived labelled proteins, administered
peripherally, appear first in the lumbar CSF and only
later in the cisternal or ventricular CSF [36], while their
concentration remains highest in the lumbar subarach-
noid space. The additional 20% of the CSF peptides are
brain-derived, however, and have the highest concentra-
tion in ventricular CSF steadily decreasing along the
flow pathway through the subarachnoid space [36].
Apparently, gradients in CSF levels exist and concentra-
tion differences of such peptides along the rostrocaudal
axis of the central nervous system tell us something
about their sources. In summary, the CSF shows an
essentially unidirectional flow and may contain brain-
derived peptides moving with the flow.
Figure 1 A schematic diagram of structures and specialized cell types bordering the different parts of the mammalian ventricular
system, and in contact with the cerebrospinal fluid (CSF). The complexity of the system suggests that CSF functions are not limited to
metabolic support of the brain and the release of waste products. Abbreviations: CO: caudal opening of the central canal of the spinal cord;H:
hypothalamic CSF-contacting neurons; HY: Hypophysis; LV: lateral ventricle; ME: median eminence; O: vascular organ of the terminal lamina; PIN:
pineal organ; R: raphe nuclei; RET: retina; RF: Reissner’s fiber; SE: septal region; SCO: subcommissural organ; SP: medullo-spinal CSF-contacting
neurons; TEL: telencephalon; TF: terminal filum; (Fig. 1 was kindly provided by Prof. B. Vigh. For details about specific cell types, the reader is
referred to: Vigh and Vigh-Teichmann, [31], and to Vigh et al, [32]).
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In the human brain, about 75% of CSF is secreted by the
choroid plexuses inside the lateral ventricles [45]. The
additional 25% is contributed by the ECF across the
ependymal layer [46]. CSF production in the young
human brain is about 500 ml/day or about 340 μl/min
[40,45]. This reduces to about 250 ml/day for the
elderly, [47]. The adult brain contains a constant volume
of about 140 ml of CSF, of which 30 ml occurs in the
ventricles and about 110 ml in the subarachnoid spaces
[40]. Therefore, human CSF is completely replaced
about three times every 24 hours. In the young adult
rat, which has about 200 μl CSF, it takes about 2 hours
to replace the CSF whereas in 30 month-old rats with
300 μl, it may take up to 8 hours for complete replace-
ment [48].
The production of CSF is under control of factors
working on both sides of the choroid plexus [29]. On
the vascular or basal side of the epithelium, noradrener-
gic and cholinergic nerves may exert direct control,
diminishing or increasing production, respectively, as
reviewed by Perez-Figares et al [46]. On the ventricular
side substances present in the CSF may influence recep-
tors on the apical surface of the choroid plexus epithe-
lium. Serotonin, for example, is probably released into
the CSF by the supraependymal plexus (see below) and
regulates CSF production via binding to 5-HT2C recep-
tors, thereby reducing CSF secretion. Similar mechan-
isms have been proposed to explain the effects of
dopamine, norepinephrine, melatonin and several pep-
tides, among them vasopressin (See [46] for review).
In addition, the composition of CSF is dependent on
t h ea c t i v i t yo fs u r r o u n d i n gb r a i nt i s s u e[ 2 9 , 3 6 ]a n do n
the activity of a specific circumventricular (CVO) organ,
the subcommissural organ and Reissner’s fiber complex
(Fig 1) [49,50]. Reissner’s fiber develops and extends
from the subcommissural organ in a caudal direction,
eventually reaching and even extending from the caudal
tip of the central canal of the spinal cord (Fig 1) [51,52].
In the adult human brain, the subcommissural organ
and Reissner’s fiber can no longer be detected [52], sug-
gesting that the fiber plays a special role during the
development of the mammalian CNS [50]. This fiber is
composed of aggregated glycoproteins and has the capa-
city to bind substances present in the CSF and most
probably affects the clearance of monoamines from the
CSF [53,54].
The subcommissural organ itself is under serotonergic
control [55], while the choroid plexus is under control
of the autonomic nervous system, which in turn is con-
trolled by a number of hypothalamic regions. These cir-
cumstances make it clear that CSF production and
composition is under the influence of an extensive set
of regulatory brain mechanisms. In addition, changes in
CSF- and intracranial pressure or a developing hydroce-
phalus seem to be involved in regulatory feedback con-
trol mechanisms [56]. In summary, both the production
and the composition of the CSF are controlled by a vari-
ety of mechanisms.
Flow and destiny of the CSF
CSF is constantly flowing inside the central nervous sys-
tem, driven by the arterio-venous pressure gradient and
the secretory processes at the choroid plexuses [36].
Two different kinds of flow, bulk flow and laminar flow,
have to be distinguished, since the mechanisms are very
different and probably subservient to very different
functions.
The bulk of the CSF flows in a caudal direction via
the third ventricle and the cerebral aqueduct to the
fourth ventricle. From there it flows either via the lateral
apertures of Luschka in all sub-primate vertebrates, and
via the additional median aperture of Magendie in pri-
mates only [57] into the subarachnoid space including
cisternae magna and pontis, surrounding the brainstem
[58,59]. Some flow may continue through the central
canal of the spinal cord but most of the subarachnoid
CSF flow apparently divides in the cisterna magna into a
cortical, rostrally directed, and a lumbar, caudally direc-
ted, component [36]. Inside the ventricular system, tur-
bulences can occur at the entrance to the narrowest
parts such as the cerebral aqueduct and central canal,
which may hinder the flow of the CSF. Such turbulences
are probably reduced by the presence of Reissner’sf i b e r
[60]. In the central canal of the rat spinal cord, CSF has
been observed to continue flowing caudally at a speed
of about 1 cm/min [60]. At the caudal tip of the spinal
cord in the filum terminale, one opening (rat) or several
openings (guinea pig, rabbit) (Fig 1) allow the CSF to
access the subarachnoid space [61]. The CSF surround-
ing the spinal cord may either rapidly re-enter the spinal
cord and central canal via perivascular spaces [62], or
leave perispinal spaces to be released into lymphatic or
venous vessels [63]. Recent human studies suggest that
spinal CSF absorption via perispinal spaces alongside
the exiting spinal nerves may account for one third of
total CSF absorbed in the resting state and considerably
more in active individuals [45].
Concerning the cranial CSF surrounding the brain,
most textbooks tell us that arachnoid granulations,
penetrating the dura and extending into the superior
sagittal sinus, compose the main outlet system for CSF
absorption in the human. Recent animal investigations,
however, have shown that at least 50% and perhaps up
to 80% or more of the CSF leaves the cranial cavity
through the cribriform plate, via the perineuronal spaces
surrounding the olfactory nerves, to drain into the nasal
and cervical lymphatics (Fig 2) [64-70]. This rostral out-
flow of CSF contains considerable amounts of interstitial
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an important role in CNS immune system interactions
[68,73].
The flow of CSF is indicated in Fig 2. Additional CSF
absorption pathways may exist alongside the vessels of
the cavernous sinus and via small lymphatic vessels
emerging from the perineuronal space of other cranial
nerves, like the trigeminal nerve [69]. These cranial CSF
exits operate in parallel to the spinal CSF exits to the
lymphatic system, mentioned before [63]. Bringing these
data together, it seems to be reasonable to hypothesize
that of all CSF produced continuously in the human
brain, about one third leaves via the spinal vessels and
one third via the nasal lymphatics, which leaves about
one third for absorption through the arachnoid granula-
tions into the superior sagittal sinus. The balance
between these absorption pathways may vary consider-
ably, however, depending on body position, physical
activity and other possible factors.
The driving force of the CSF bulk flow is actively sup-
ported by arterial pulsations as proposed by Bering [74],
in the choroid plexus or by arterial and brain expansion
mechanisms [75-78]. A decade ago, these temporarily
neglected expansion mechanisms started to receive
attention again because of potential clinical relevance
[46,79-83] and age related changes [84].
The laminar flow of CSF occurs in a thin layer along
the ventricular walls and is not necessarily restricted to
directions from rostral to caudal. Directional beating of
ependymal cell cilia lining the ventricular wall, seems to
be the most important factor for this flow [60,85,86].
The ciliary movements may contribute to the mixing of
the CSF, are supported by a sialic acid-induced hydra-
tion mantle on the ventricular surfaces and are stimu-
lated by release of serotonin from the supraependymal
serotonergic terminals. In addition to transport of neu-
roactive substances, a rostrally-directed laminar flow
may be crucial for newborn neurons to reach their final
location (see below). Both bulk and laminar flow seem
to be prerequisites for normal CSF functioning, since
disturbance of either the ciliary movements or Reissner’s
fiber both perturb CSF flow to such an extent that
hydrocephalus develops [87,88].
In summary, the flow of the CSF comprises two differ-
ent mechanisms. Bulk flow is driven by arterio-venous
pressure gradients and arterial pulsations, traversing the
ventricular system in a caudal direction towards the
brainstem apertures. From there the subarachnoid CSF
flow can be described as bidirectional: either descending
to the spinal cord or ascending to the dorsal and rostral
parts of the brain. Since in the latter, cranial, compart-
ment the main exit of the CSF appears to be along the
olfactory nerves through the cribriform plate, there
Figure 2 A schematic diagram showing the direction of the CSF bulk flow in the mammalian brain based on a midsagittal section of
the rat brain, kindly provided by Prof. L.W. Swanson. The following regions are indicated: telencephalon (pink shades); diencephalon
(interbrain) and brainstem areas (yellow shades); cerebellum dorsal to the brainstem (light blue); sectioned fiber tracts (black). CSF (blue arrows)
flows from the lateral ventricles to the third ventricle via the interventricular foramen (IVF), and flows caudally along the dorsal and ventral side
of thalamic adhesion, to the cerebral aqueduct (AQ) and fourth ventricle (V4). Some CSF may continue flowing caudally through the central
canal of the spinal cord (CC), but most leaves the ventricular system via the lateral apertures and flows through the subarachnoid space,
surrounding the brain. This external flow is indicated here along the dorsal and ventral side of the brain but occurs also along all other external
brain surfaces. The destination of the subarachnoid flow is the cribriform plate of the ethmoidal bone, containing the penetrating olfactory
fibers, where CSF is released in small lymphatic vessels. Additional abbreviations: V3(p, h, m, t, pi): regions and recesses of the third ventricle;
Circumventricular organs: 1: subfornical organ; 2: organum vasculosum of the lamina terminalis; 3: median eminence; 4: subcommissural organ; 5:
pineal organ; 6: area postrema; AL, IL and NL: different lobes of pituitary; Fiber bundles crossing the midline, coloured black, are not relevant for
the present review.
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subarachnoid CSF flow. The laminar flow occurs only
inside the ventricular system in a very thin layer along
the walls in a variety of directions and driven by the
beating of the cilia of local ependymal cells. Interruption
of either bulk or laminar flow results in hydrocephalus.
The CSF circulation during development and aging of the
CNS
Recently, it was shown in mice that ependymal ciliary
beating, inducing laminar flow, is a prerequisite for the
migration of new neurons from the subventricular zone
to the anteriorly located olfactory bulb [89]. Even in the
adult human brain, newly formed neuroblasts follow
this path between the subventricular zone and the olfac-
tory bulb. This path is referred to as the rostral migra-
tory stream [90]. Apparently, supported by gradients of
brain-derived neurotrophic factor (BDNF) levels in the
CSF [91], the neuroblasts know how to go with the
laminar flow.
Experimental evidence suggests that during develop-
ment of the brain, messages from specific parts of the
ventricular system are essential for the formation of the
layered structure of the cortex [92]. This suggests that
specific messages released into the CSF at a specific
time point, influence not only functional but also impor-
tant structural aspects of distant target areas. In addi-
tion, such findings suggest that the targets for CSF
messages may not be limited to the periventricular areas
inside the brain but may be present at the outer surface
of the brain as well.
The features of the walls lining the ventricular system
also change over time. In the rat brain, ependymal cells
appear from gestational day 16 [93]. The function of the
ependymocytes as well as the permeability of the epen-
dyma is age-dependent [94-96] and contributes to the
changes with age in composition of the CSF [48,96]. In
elderly humans CSF production and flow rate decrease,
affecting protein concentrations [36] demonstrating that
clear functional changes occur in the third circulation
with increasing age.
Clinical evidence shows that changes occurring in the
composition of the CSF and in the homeostatic balance
of freely exchanging CSF and ECF compartments with
age [36], are possibly involved in brain diseases such as
Alzheimer’s [48,97]. On the one hand, such changes in
the composition of the CSF may profoundly affect the
paracrine messages transmitted via the CSF. On the
other hand, it may facilitate new opportunities for the
treatment of brain diseases as prospects are improved
for drug delivery and brain targeting via the CSF for
multiple brain diseases [98]. In summary, CSF flow
plays an important role in the structural development of
the CNS. The laminar flow is involved in the guidance
of neuroblasts and the bulk flow in delivering messages
obtained from the brainstem to guide cortical develop-
ment. The composition of CSF and CSF-ECF exchange
are profoundly affected by the aging process and may be
related to brain diseases, suggesting an opportunity for
treatment by targeting drugs via the CSF.
CSF composition, sources, targets and exchange with ECF
Sources of CSF contents
In addition to blood-derived proteins in the CSF
(approximately 80%), the other proteins (about 20%) ori-
ginate from within the CNS, from neurons, glial and
leptomeningeal cells [36]. The choroid plexus itself
synthesizes proteins, some of them abundantly, such as
transthyretin, a carrier for thyroid hormones. Once
secreted into the CSF, such proteins are thought to
influence distant parts of the brain [99]. The direct or
indirect activation of brain areas bordering the ventricu-
lar system or subarachnoid space has been shown to
result in increased levels of neuropeptides released into
the CSF [100-102]. The circadian variations in CSF con-
centrations without concomitant changes in peripheral
concentrations provide additional evidence for selective
release of neuropeptides such as oxytocin into the CSF
[103-106]. Specific dendritic release mechanisms occur
in brain areas such as the paraventricular and supraoptic
hypothalamic nuclei, leading to as much as a thousand
fold increase in the local ECF peptide concentrations
[107]. Experiments involving ablation and transplanta-
tion of the suprachiasmatic nucleus in the golden ham-
ster showed that the release of a diffusible signal was
most likely carried by the flow of CSF [108,109].
Recently, it has been shown that in the diurnal grass rat,
the suprachiasmatic nucleus releases at least some of its
contents into the CSF in order to reach specific target
areas [110]. Taking together the available evidence, we
suggest that the active release of neuropeptides into the
CSF has to be considered as a probable mechanism for
message transmission via the CSF to distant brain areas,
as was previously discussed during a special conference
in 1998 [26].
In addition to the neuronal release from specific brain
areas, the presence of widespread supraependymal cell
clusters, fibers and plexuses of neuronal and other cellu-
lar elements, including macrophages, have been
described since the early seventies [32,111]. Their abun-
dant presence near the median eminence suggests that
these supraependymal elements are involved in a variety
of functions [112-117] (Fig 3A, B). Among these, seroto-
nergic fibers have been described as originating from
the raphe nuclei with nerve terminals located in the
CSF. These fibers are thought to release their content
differentially from several parts of the ventricular walls
of the mammalian ventricular system into the flowing
CSF [111,112,117-121] (Fig 3C).
Veening and Barendregt Cerebrospinal Fluid Research 2010, 7:1
http://www.cerebrospinalfluidresearch.com/content/7/1/1
Page 6 of 16In addition to the supraependymal elements, many
fibers containing specific neuroactive substances can be
observed in the subependymal layer. Many of these are
of hypothalamic origin and may contain peptides like
luteinising hormone releasing hormone (LHRH), CRF or
adreno-corticotropic hormone (ACTH) [12,14,122].
Others originate in the dorsal periaqueductal gray to
descend towards the cervical and upper thoracic spinal
cord, many of them contacting the perivascular spaces
[22]. Many of these descending fibers are characterized
by large numbers of varicosities or local swellings con-
taining numerous vesicles but without synaptic speciali-
sations. The presence of such varicosities suggests that a
single fiber may release its contents over large distances,
by non-synaptic release or exocytosis, either into the
CSF or for diffusion into the bordering ECF to influence
a population of receptive neurons [12,14,31,32].
From the available data, no clear general function can
be derived for these supra- and sub-ependymal ele-
ments. However, their differential distribution over spe-
cific regions of the ventricular walls strongly suggests
two possibilities: local effects and/or specific effects on
receptive distant target areas. Two interesting cases of
substances released into the third ventricle, going with
the flow to reach their target areas, have been studied in
detail so far: melatonin and the LHRH system, also
known as the gonadotropin-releasing hormone (GnRH)
system.
The pineal gland produces the hormone melatonin at
night. The gland is located dorsal to the third ventricle
and has access to the CSF via the pineal recess [123]. In
a series of experiments in sheep, it was shown that the
main effects of the pineal gland occurred through
release of melatonin into the dorsal tip of the third ven-
tricle. At the exit of the pineal gland, concentrations
were about 10 times higher than in the rest of the ven-
tricular system and about 100 times higher than in per-
ipheral blood [123,124]. Melatonin is not only secreted
into the CSF but also into the general circulation
[124,125], which makes the situation more complex.
Melatonin also regulates the CSF levels of another hor-
mone, estradiol [126], which may result in additional
indirect effects. However, its main site of action to con-
trol reproduction is located in the premammillary
hypothalamic nucleus, where it stimulates luteinizing
hormone secretion in the ewe [127]. Apparently,
Figure 3 (A and B) show scanning electron microscopy of supraependymal structures in the rat brain. A: Partially ensheathed fibers and
terminal arborizations; B: cellular structures with short fiber extensions, on the ventricular surface of the ependymal cells; Fig 3C: a schematic
diagram of the ependymal layer with supra- and subependymal cellular structures contacting the CSF at the ventricular side of the layer; the *
indicates a supraependymal terminal extending into the CSF, as described for serotonergic fibers. Figs 3A and 3B were reprinted from [121], with
permission of Springer-Verlag. Fig 3C was kindly provided by Prof. B. Vigh.
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to the premammillary hypothalamus are involved.
Another example is posed by the neuropeptide: LHRH
also known as GnRH. This neuropeptide is released in a
pulsatile manner into the portal system and stimulates
the pulsatile gonadal hormone production of the pitui-
tary [128,129]. However, GnRH is released into the CSF
as well, and this CSF GnRH neither functions as a feed-
back system for controlling GnRH production, nor does
it directly affect the pituitary gland [130]. The influx of
peripheral GnRH across the blood-brain barrier into the
CSF is so limited that it cannot explain the observed
levels of CSF GnRH which are comparable to those in
the portal blood stream [131]. These findings, combined
with detailed measurement of GnRH concentrations at
different sites in the ventricular system suggest that
GnRH is released directly into the CSF and the third
ventricle. This occurs at the level of the median emi-
nence, and possibly the organum vasculosum of the
lamina terminalis (OVLT) (indicated as ME and O in
Fig 1) where GnRH immunoreactive (IR) perikarya and
axons are very abundant [128,131]. The authors con-
clude that the function of CSF GnRH expresses itself in
behavioral effects, induced by volume transmission via
the flow of CSF to affect distant brain areas, such as
periaqueductal gray (PAG) and hippocampal regions.
These regions contain, indeed, high densities of GnRH
receptor expressing neurons, while GnRH-IR axons are
either scarce (PAG) or completely lacking [12,15,131].
The PAG is strongly involved in sexual behavior
[132-135] which can be elicited by intraventricular (icv)
but not by intravenous administration of GnRH [136].
These findings concerning the distribution and beha-
vioral effects of melatonin and GnRH via the CSF com-
prise, in our view, compelling evidence for CSF
messages controlling aspects of behavior.
That the exact site of release of a neuropeptide into
the ventricular system is the determining factor for its
given effects, has been shown in experiments involving
transplants of the suprachiasmatic nucleus in the
hypothalamus [109,137]. Research aimed at identifying
the mechanisms regulating food intake, such as experi-
ments involving delivery of substances into either the
third or the fourth ventricle, with an open or an experi-
mentally-closed cerebral aqueduct, have shown that
caudally-flowing substances and neuropeptides (glucose,
leptin, neuropeptide tyrosine (NPY) reach specific recep-
tive areas to influence food intake [138-140]. Appar-
ently, most factors, influencing food intake, like cocaine-
and amphetamine-regulated transcript (CART), bombe-
sin and oxytocin, exert their effects in the caudal brain-
stem [141-144], while other factors are only effective in
or around the third ventricle (NPY and calcitonin
[140,145].
In summary, about 80% of the CSF proteins are
derived from the blood [146] while about 20% are pro-
duced by the brain. Brain areas bordering the ventricular
system as well as supra- and subependymal cells and
fibers lining the ventricular walls are in the most favour-
able position to add such substances to the CSF. Mela-
tonin and GnRH, both released into the third ventricle
but at different locations, and the experiments concern-
ing substances controlling food intake administered into
either the third or the fourth ventricle, and moving with
the flow, are good examples for local additions into the
CSF influencing remote brain areas. Apparently, the site
of upstream release determines which downstream areas
will be affected.
Flow-transport: speed and mechanisms
The question can be raised whether the flow-transport
mechanisms work rapidly enough to induce behavioral
effects in a relevant timescale. A quick survey of the lit-
erature shows that the time between administration or
release of neuropeptides into the CSF and the observed
behavioral or physiological effects turns out to be very
short. In a series of experiments involving respiratory
and cardiovascular control mechanisms in the cat,
effects of icv administration of respiratory stimulants
such as vasopressin into the lateral ventricle were
observed within two minutesa tt h ev e n t r a ls u r f a c eo f
the brainstem. Since this surface lies beyond the fora-
mina of Luschka, this finding indicates that the stimulus
was moving with the CSF flow in the cat brain at a
speed of more than 1 cm/min [57]. A tracer like HRP
carefully administered into the lateral ventricle of the
cat in order to avoid direct pressure effects, penetrates
the outer surface of the brainstem within four or five
minutes (see below) [25]. A similar rapid distribution of
at r a c e r[
14C]Inulin as well as of [
125I]CRH after admin-
istration into the lateral ventricle has been observed in
the rat [147]. Other data obtained from the rat also
show rapid flow transport of neuropeptides. a-Melano-
cyte stimulating hormone (aMSH) injected into the lat-
eral ventricle appeared within two minutes in the
cisterna magna [148]. b-endorphin was observed in the
CSF within minutes after electrical microstimulation of
the arcuate hypothalamic nucleus, without any change
in peripheral levels [100,149]. Both interleukin-1 and
CRF have been shown to induce widespread effects
throughout the brain, starting a few minutes after icv
administration [150,151]. The effects of icv oxytocin on
ventromedial hypothalamic neurons is manifest in under
one minute [152]. Fenstermacher and his group showed
a similar rapid distribution via the ventricular system,
however their findings revealed that the flow over the
cortical surface was considerably slower [146,153,154].
Recent measurements of the pulsatile flow rates in the
cerebral aqueduct of the human brain by modern
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speed of this CSF transport channel [75,78,83]. Maximal
flow rates of 12 mm/s and higher were observed in the
aqueduct [58,59], while at other sites like the spinal
canal, the flow rate was almost negligible [58].
In summary, transport of CSF contents by bulk flow is
fast, working on a time scale of minutes, and is directly
relevant for behavioral and physiological adaptations.
Exchange of substances between CSF and ECF: mechanisms
and targets
Exchange of fluid contents between the ECF in the neu-
ropile and the ventricular CSF occurs via different
mechanisms and at different rates: 1: diffusion, 2: peri-
vascular pump mechanisms, and 3: tanycytes and ECF-
contacting neurons.
1: Diffusion. This is a rather slow process, depending
on ECF diffusion parameters like volume fraction, tortu-
osity and the diffusion coefficient of the neuroactive
substance [155-157]. Diffusion in the ECF compartment
may appear anisotropic, due to the hindrances imposed
by local differences in tortuosity [155]. White matter
tracts are guiding tracts for the interstitial fluid flow as
well as for the dissemination of primary brain tumors
[158]. Diffusion and exchange between cerebrospinal
and extracellular fluid compartments may occur in both
directions [37,77] through an uninterrupted single-
layered lining of the ventricular system, consisting of
several types of ciliated ependymal cells [95,159]. Due to
the lack of tight junctions between ependymal cells, the
CSF-ECF barrier can be described as open or non-exis-
tent. In that respect, the CVO’s form a notable excep-
tion with a closed CSF-ECF barrier and an open blood-
ECF barrier (usually called blood-brain barrier, or BBB),
(see McKinley et al[160]). Interestingly from a cyber-
netic point of view, the open CSF-ECF compartment
throughout the brain is functionally separated from the
open BBB-ECF compartment inside the CVO’s. These
two compartments can be described as being disjoint or
even complementary, but the direct neuroanatomical
relationships between the paraventricular hypothalamic
nucleus and the CVO’s [161-168] manage the bidirec-
tional communication and mutual tuning of both
compartments.
In general, concentration differences and gradients
determine the direction of the diffusion between CSF
and ECF. High levels of neuroactive substances in the
CSF will enter the ECF, while high local concentrations
in the ECF will diffuse into the CSF. For brain areas like
the medial hypothalamus, as well as the periaqueductal
gray, such diffusion processes will result in continuous
equilibration processes in the levels of neuroactive sub-
stances involved in the induction or maintenance of
behavioral states. Widely divergent substances and tech-
niques have been used to measure diffusion distances.
Diffusion over distances of 0.5 mm and at other sites up
to 1 mm away from the wall of the third ventricle, from
the cerebral aqueduct and from the floor of the fourth
ventricle [25,147,151,169,170] are reasonable estima-
tions. In rat brain, areas such as the lateral septum and
parts of the bed nucleus of the stria terminalis, the dor-
sal midline thalamus and habenular nuclei, the medial
hypothalamic regions, the mesencephalic periaqueductal
gray as well as several brainstem core and paracore
areas [7] can, therefore, be influenced directly by the
composition of the CSF. Diffusion of any relevant sub-
stance from the CSF into these regions would influence
a number of behavior-relevant brain functions [27].
Diffusion in the other direction, that is from the ECF
into the CSF occurs as well and may also play a role
over larger distances. This situation was observed after
infusion of a small amount of beta-endorphin into the
striatum of the rat [171]. Despite the considerable dis-
tance to the ventricular system, the infused beta-endor-
phin appeared in the CSF within 10 minutes, reaching
peak values in the cisterna magna after about 30 min-
utes [171]. This experiment shows that diffusion within
the brain may occur over considerable distances and in
a behaviour-relevant time-scale during the CSF-ECF
exchange processes.
On the other hand, many different substances have
been injected into the ventricular system of a variety of
vertebrates and a speed and depth of penetration has
been observed which far exceeds the capabilities of dif-
fusion. Apparently, active transport processes are
involved as well. Two of these will be described.
2: Perivascular pump mechanisms have been shown to
play an important role in the distribution of CSF con-
tents. The pump involves the perivascular space of ves-
sels penetrating the outer surface of the brain and is
driven by the arterial pulsations of the cerebral vessels
[172,173]. The differences between the passive diffusion
processes are striking. While the diffusion rate of the
neuroanatomical tracer horseradish-peroxidase (HRP) in
brain tissue amounts to less than 1 mm/hr, after an
intraventricular or cisternal injection, HRP can be
observed along all microvessels of the neuraxis. HRP
molecules penetrated deeply (several mm) within five
minutes [172]. This fast spread occurs along perivascular
spaces and is aided by a paravascular fluid circulation
system, driven by the pulsations of the cerebral arteries.
In parallel to an inward flow along the arterial perivas-
cular spaces, an outward flow may occur along the
venous paravascular routes, adding interstitial fluid to
the ECF/CSF in the subarachnoid space [172,174]. The
existence of these paravascular routes provides the neu-
roactive CSF contents with a widespread and fast portal
to enter less superficial brain areas and to affect a much
larger variety of regions in brain or spinal cord
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[
14C]inulin was used, confirmed the rapid and extensive
distribution of icv-injected substances. Interestingly, it
was concluded that the paravascular fluid circulation
may even preferentially target specific brain areas like
the hippocampus, the basal forebrain including the
hypothalamus and the ventral brainstem surface [147].
This perivascular pump has been described as a “power-
ful mechanism for the distribution of therapeutic mole-
cules within the brain” [173]. Similar mechanisms may
support neuropeptides released into the CSF to reach
remote destinations. GnRH, for example, could reach
the hippocampal regions, which are richly supplied with
GnRH receptors while a GnRH innervation is virtually
lacking [131].
3: In addition to the slow diffusion mechanisms for
local/regional effects and the rapid perivascular pump
mechanisms, involving the whole or some preferential
large parts of the brain, special ependymal cells (tany-
cytes) and neurons contact the CSF in order to interna-
lize specific constituents, to release them at specific sites
and for specific purposes, and are not covered by the
general mechanisms mentioned before.
Tanycytes compose a specific group of ependymal
cells. Those lining the ventral part of the third ventricle
have basal processes that extend to the hypophyseal-
portal vasculature as well as into the mediobasal
hypothalamus, suggesting a role in pituitary and neural
control. As reviewed by Bruni [95] and Rodriguez et al.
[177], multiple tanycyte functions have been proposed
over time. Tanycytes can be observed also in the walls
of the lateral and fourth ventricles as well as along the
central canal of the spinal cord [178]. Tanycyte exten-
sions apparently radiate from the third ventricle into
hypothalamic nuclei, but also laterally into the caudate
putamen or, from the floor of the fourth ventricle, ven-
trally into the lower brainstem areas [178]. Several types
of tanycytes have been described with specifically differ-
ent endocytotic mechanisms [179,180]. Some of these
recent experiments compared peripheral and icv admin-
istration of tracers and neuropeptides and the distribu-
tion and tanycyte-labelling patterns inside the brain
were very different [179,181]. This suggests that tany-
cytes of a given type are specifically selective, each one
retrieving a different substance from the CSF and
underlining the highly specific nature of tanycyte mes-
sages. Our understanding of the functional effects tany-
cyte messages is only preliminary and major steps for
elucidating their role, remain to be taken.
Very recently, melanocortin-concentrating-hormone-
(MCH) immunoreactive ependymal cells, extending
between the floor of the 4
th ventricle and the midbrain
raphe nuclei have been reported [182]. The authors con-
cluded that these elongated tanycytes internalized MCH
released from the hypothalamus into the CSF, to act on
specific target neurons in the dorsal raphe nucleus.
Since serotonergic neurons are numerous in this mid-
brain raphe nucleus, internalization of MCH followed by
release from these specific tanycytes may have far-reach-
ing effects on serotonergic transmission and therefore
on behavior.
Additionally, neurons may directly contact the CSF
[31,32]. Such neurons have been observed at a consider-
able distance from the ventricular system. Some use
selective receptor-mediated uptake mechanisms to
obtain specific substances from the CSF and have been
observed in brain areas such as the hippocampus, sep-
tum and cortex [170]. Other CSF-contacting neurons
were observed in anterodorsal thalamus, supramammil-
lary nucleus, dorsal raphe nucleus, the floor of the
fourth ventricle as well as in the lateral superior olive
nucleus [178]. This implies, for example, that if the
supramammillary region is functionally affected by the
CSF contents, the activity of the whole septohippocam-
pal complex is involved, linking functional (learning)
and behavioral (fear/anxiety) consequences to the com-
position of the CSF. In particular, the dorsal raphe
nucleus seems to have strong links with the CSF, with
several CSF-contacting groups of neurons [178,183] in
addition to the special tanycytes, mentioned before.
Recently, it was shown that the locus coeruleus accumu-
lates about 50% of a nerve growth factor, not by neuro-
nal transport mechanisms but directly from the CSF
[184]. Taken together with the special MCH-transmit-
ting ependymal cells, [182], the activity of the raphe
neurons or the serotonergic system, as well as the locus
coeruleus neurons or the noradrenergic system, are
under control of factors circulating in the CSF. Consid-
ering that most of these findings are very recent, it is
only to be expected that during the next few years more
brain areas and more functional and transmitter systems
will be discovered that derive part of their controlling
information from CSF.
In summary, the interaction between the CSF and its
contents occurs in three different but complementary
ways: 1) diffusion: a slow and local process, over short
distances, 2) via perivascular spaces and an active overall
pump system driven by the vascular system, and 3) spe-
cific uptake mechanisms: depending on the receptors
exposed to the CSF.
The existence of these mechanisms fully supports the
original notion of Borison et al, (1980) that “the simple
concept that the subarachnoid space constitutes a catch
basin for interstitial fluid is no longer tenable. Rather,
the CSF of that space must be considered as being in
dynamic chemical communication with all parts of the
central nervous system” [25]. These mechanisms are in
full agreement with the conclusions drawn by Abbott
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tial fluid (ISF = ECF) flow, including the CSF [185]
“Chemical signals produced within the brain are able to
use the flowing ECF (= ISF) as a communication route”,
with rapid bulk flow occurring within the CSF system, ...
“or vectorial signalling from upstream to downstream
sites”. These mechanisms are ... “extending the sphere of
influence of a bioactive molecule beyond that which
c o u l db ea c h i e v e db yd i f f u s i o n ”... “and provide the basis
for a site specific communication pathway, by which
molecules released from site A could be specifically
designed to be carried to and influence site B” (pp
550,551). Specificity and range would be determined by
factors like the anatomy of the communication route, by
the presence of appropriate receptors and by activation
mechanisms to limit or confine the signal spread [185].
Abbott (2004) concludes that “the ability to predict the
effects of ECF/ISF flow ... is likely to play an important
role in developing future therapeutic strategies for CNS
targeting and repair”.
Neuropeptides form an integral part of the CSF
composition
In the preceding sections, it has been mentioned that
many neuropeptides have been found in the CSF. For
many of them, CSF levels bear hardly any relationship
to peripheral levels in the blood, and they are actively
secreted by choroid plexus, glial and neuronal cells into
the CSF [36]. Active release of neuropeptides from brain
areas bordering the ventricular system with the aim or
at least the effect of influencing downstream brain areas
at a distance, has been repeatedly observed for a range
of different neuropeptides and transmitters
[12,14,36,42,99,102,108,123,129-131,136,184,186-188].
Sewards and Sewards [28] discussed extensively the evi-
d e n c ea v a i l a b l ef o rt h en e u r o peptides vasopressin and
corticotrophin-releasing-hormone, and concluded that
these were actively secreted into the CSF to influence
downstream receptive areas involved in specific kinds of
behavior.
An interesting recent paper [189] showed the exis-
tence of numerous nanoparticles in the CSF, composing
a “matrix of membrane- and protein rich nano-scaled
structures with many transduction components bounded
by lipid membranes”. They concluded that this “bulk
flow of nanostructures generates a more dispersed signal
delivery, of longer duration”,i no r d e rt o“regulate brain
behaviors known to require slower, more gradual, and
more sustained modulations, such as reported for sleep,
appetite, mood and vasomotor regulation”. This conclu-
sion is in full agreement with our hypothesis as pro-
posed in the present review.
In summary, there are convincing indications for neu-
ropeptide release into the CSF, and for transport via the
CSF bulk flow as a special kind of volume transmission
towards receptive brain areas, to propose a message
function for specific CSF contents.
Behavioral effects of CSF contents
The question that remains is: what are the functional
significances and the specific contributions of such rela-
tively uncontrolled and broad-spectrum CSF-release sys-
tems, in addition to precisely targeted synaptic or more
diffuse non-synaptic release mechanisms? Many
instances have been discussed above such as melatonin,
GnRH, feeding experiments with administration into the
3
rd or 4
th ventricle, that provide evidence for peptidergic
and other signals that arrive at their target areas via the
CSF at a concentration level sufficient to induce obvious
behavioral changes. Taken together, with the many
papers reporting that administration of substances into
CSF is much more effective than peripheral administra-
tion for inducing behavioral changes, we judge the evi-
dence as overwhelming for the statement that the CSF
(the third circulation) contains meaningful messages to
be recognized by the appropriate sensitive brain target
areas to elicit a neural and physiological/behavioral
response. Therefore, we support the view that broad-
casting messages via the CSF is an appropriate way to
put several parts of the CNS into a behavioral state.
Such a brain state is subservient to the performance of
specific behaviors or groups of behavioral elements that
share a common motivational system and may include
the temporary suppression of specific behavioral or phy-
siological reactions. These CSF messages have to be
considered as a partially-independent signal. Simulta-
neously, these messages are constantly supporting, sus-
taining and in mutual exchange with the ECF contents
released by axon terminals all over the brain and specifi-
cally in brain areas adjoining the CSF.
Sewards and Sewards [28] proposed that the presence
of elevated CSF levels of CRF are involved in the moti-
vation of fear while the presence of vasopressin is
involved in the power-dominance drive motivation.
They hypothesized that the elevated neuropeptide levels
in the CSF are detected and transduced into neuronal
activities by, predominantly, hypothalamic neurons in
the vicinity of the third ventricle. The purpose of this
system was proposed to maintain a state of fear or
anger and consequent vigilant or aggressive behavior,
after the initial fear- or anger-inducing stimulus itself is
no longer perceptible [27]. In other words, CSF mes-
sages prolong the duration of a motivated state. Interest-
ingly, important destination areas for this transmission
(the medial hypothalamus, periaqueductal gray, midline
thalamus and medial) prefrontal cortex are all bordering
the CSF system, at the inner or outer surface of the
brain. In addition, each of these destination areas is
extensively connected to other parts of the limbic
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motivated behaviors [27].
The time scale of these effects, starting within minutes
but extending over time [57] up to more than an hour
[190,191] are fully appropriate to induce and sustain
behavioral changes reflecting a modified behavioral state
of the animal. The anatomical observations of many var-
icose peptidergic fibers present close to and in parallel
to the ventricular system [12-15,22] suggests that mes-
sages arriving via the axons by terminal and varicosity
release may be supported by messages arriving via the
CSF in a mutually sustaining way, because of the free
exchange between ECF and CSF. Such sustaining CSF
messages in harmonic balance with neuronal communi-
cation mechanisms are in a perfect position to play a
role in the rise and decline of successive motivational
states and for necessary transitional states.
Conclusions
There is considerable evidence that peptidergic and
other substances are actively secreted into and distribu-
ted via the CSF spreading with surprising speed to many
brain areas. We propose that they can be considered
functionally as messages, because their presence can
influence the activity of specific groups of receptive neu-
rons, located near the ventricular and subarachnoid sur-
faces of the brain, downstream from the site of release.
As such messages remain active considerably longer
than a few seconds, they may form part of the mechan-
isms underlying the changes in successive behavioural
states.
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